Fawzi Adab

TL;DR: Sparing the parotid glands with IMRT significantly reduces the incidence of xerostomia and leads to recovery of saliva secretion and improvements in associated quality of life, and thus strongly supports a role for IMRT in squamous-cell carcinoma of the head and neck.

TL;DR: Among men with locally advanced or metastatic prostate cancer, ADT plus abiraterone and prednisolone was associated with significantly higher rates of overall and failure‐free survival than ADT alone.

TL;DR: GEM-CAP should be considered as one of the standard first-line options in locally advanced and metastatic pancreatic cancer and the meta-analysis of published studies showed a significant survival benefit in favor of GEM- CAP.

TL;DR: Resection margin-positive pancreatic tumors represent a biologically more aggressive cancer; these patients benefit from resection and adjuvant chemotherapy but not chemoradiation; the magnitude of benefit for chemotherapy treatment is reduced for patients with R1 margins versus those with R0 margins.

TL;DR: The data suggests that the optimum time for assessment of complete clinical response after chemoradiotherapy for patients with squamous cell carcinoma of the anus is 26 weeks from starting chemoradaotherapy, and that guidelines should be revised to indicate that later assessment is later.